News | April 11, 2024
Asahi Kasei Bioprocess and Axolabs partner to accelerate oligonucleotide therapeutics development
The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility
The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility
Aurigene.AI is an end-to-end solution for small molecule drug discovery
The facility will manufacture Specialty and Fine Chemicals tailored to various applications across industries such as Polymer and Water Treatment facilities
With this, the total number of Patents granted to company for its innovative processes and technology stands at 9
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
Astellas has acquired abiraterone decanoate being developed by Propella to treat prostate cancer
Collaboration enables Brenntag to serve pharma customers in EMEA with chromatography silica gels
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
Subscribe To Our Newsletter & Stay Updated
